Citigroup has increased its price target for Ventas (VTR) to $96 from $88, while reiterating a Buy rating on the stock. This adjustment reflects continued analyst confidence in the healthcare REIT. The article also lists several other financial institutions that have recently updated their price targets and ratings for Ventas.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Citigroup Adjusts Ventas Price Target to $96 From $88, Maintains Buy Rating
Citigroup has increased its price target for Ventas (VTR) to $96 from $88, while reiterating a Buy rating on the stock. This adjustment reflects continued analyst confidence in the healthcare REIT. The article also lists several other financial institutions that have recently updated their price targets and ratings for Ventas.